Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Aldosterone synthesis and secretion,0.011234671910231168,3.430834487534626,15.400160282915003,"['NR4A2', 'NR4A1', 'CYP11A1', 'ATP1B3', 'CACNA1D', 'ATP2B2']",0.9999670772068849,0,0,6
2,Aminoacyl-tRNA biosynthesis,0.022948636792460477,5.462225274725275,20.61715151040904,"['MTFMT', 'EARS2', 'FARSB']",0.9999670772068849,0,0,3
3,Mineral absorption,0.025819010289425535,3.8384804987675802,14.035957550356219,"['ATP1B3', 'SLC30A1', 'ATP2B2', 'CLCN2']",0.9999670772068849,0,0,4
4,RNA degradation,0.04431684410202284,2.722849839201781,8.48546322522428,"['EXOSC7', 'EXOSC9', 'DHX36', 'WDR61', 'MPHOSPH6']",0.9999670772068849,0,0,5
5,Arginine biosynthesis,0.04629067913912671,6.607222914072229,20.30277138366044,"['GLUD1', 'ACY1']",0.9999670772068849,0,0,2
6,Tyrosine metabolism,0.04629067913912671,6.607222914072229,20.30277138366044,"['DCT', 'MAOA']",0.9999670772068849,0,0,2
7,Cardiac muscle contraction,0.07400259263718495,2.648635111445029,6.89613245038192,"['MYL3', 'ATP1B3', 'CACNA1D', 'UQCRC2']",0.9999670772068849,0,0,4
8,Proximal tubule bicarbonate reclamation,0.0752594445927076,4.843835616438356,12.530101174482171,"['GLUD1', 'ATP1B3']",0.9999670772068849,0,0,2
9,Arginine and proline metabolism,0.08677069348400598,3.0309065934065935,7.409009786612633,"['MAOA', 'LAP3', 'L3HYPDH']",0.9999670772068849,0,0,3
10,Cortisol synthesis and secretion,0.08677069348400598,3.0309065934065935,7.409009786612633,"['NR4A1', 'CYP11A1', 'CACNA1D']",0.9999670772068849,0,0,3
11,Serotonergic synapse,0.10167283498846258,2.3483515506975916,5.36832018697196,"['MAOA', 'DUSP1', 'CACNA1A', 'CACNA1D']",0.9999670772068849,0,0,4
12,D-Glutamine and D-glutamate metabolism,0.10335442578389262,12.087431693989071,27.43352824683875,['GLUD1'],0.9999670772068849,0,0,1
13,Mismatch repair,0.10843224212204663,3.822927180966114,8.493128939487416,"['POLD3', 'RFC3']",0.9999670772068849,0,0,2
14,Porphyrin and chlorophyll metabolism,0.10843224212204663,3.822927180966114,8.493128939487416,"['FECH', 'EARS2']",0.9999670772068849,0,0,2
15,RIG-I-like receptor signaling pathway,0.11428437236436924,2.6602787456445993,5.770318693930484,"['TRAF3', 'TRIM25', 'ISG15']",0.9999670772068849,0,0,3
16,Ribosome biogenesis in eukaryotes,0.11479709663493644,2.239457512184785,4.847505289554425,"['XPO1', 'HEATR1', 'MPHOSPH10', 'MDN1']",0.9999670772068849,0,0,4
17,Tight junction,0.12442248778883482,1.82202216066482,3.797225997031955,"['PPP2R2C', 'CACNA1D', 'AMOTL1', 'ACTR3B', 'JAM2', 'JAM3']",0.9999670772068849,0,0,6
18,Ubiquitin mediated proteolysis,0.13833387035229947,1.7627111071396657,3.4867926918522727,"['UBA7', 'UBE2Q2', 'UBR5', 'UBE2D1', 'UBE3B', 'PIAS1']",0.9999670772068849,0,0,6
19,Phenylalanine metabolism,0.15096441933491855,7.251366120218579,13.710238438872343,['MAOA'],0.9999670772068849,0,0,1
20,Phosphonate and phosphinate metabolism,0.15096441933491855,7.251366120218579,13.710238438872343,['SELENOI'],0.9999670772068849,0,0,1
21,Ether lipid metabolism,0.15404158231524034,3.0253424657534245,5.659002004785203,"['PLA2G5', 'SELENOI']",0.9999670772068849,0,0,2
22,Influenza A,0.16154078390750695,1.7837991550211245,3.251861643175407,"['IL33', 'XPO1', 'RSAD2', 'TRAF3', 'TRIM25']",0.9999670772068849,0,0,5
23,Hepatitis C,0.16592616106295366,1.7663466180335783,3.172733702351586,"['RSAD2', 'PPP2R2C', 'TRAF3', 'EIF2AK3', 'PIAS1']",0.9999670772068849,0,0,5
24,Carbohydrate digestion and absorption,0.17318268617568552,2.7922023182297155,4.895870586579724,"['CACNA1D', 'ATP1B3']",0.9999670772068849,0,0,2
25,Hematopoietic cell lineage,0.17318268617568552,2.7922023182297155,4.895870586579724,"['CD9', 'CD59']",0.9999670772068849,0,0,2
26,Arrhythmogenic right ventricular cardiomyopathy,0.17722306170572263,2.137039431157078,3.6978178542525066,"['ACTN2', 'ITGA7', 'CACNA1D']",0.9999670772068849,0,0,3
27,Adrenergic signaling in cardiomyocytes,0.18853395920559457,1.6839318600368325,2.8096018026468643,"['PPP2R2C', 'MYL3', 'ATP1B3', 'CACNA1D', 'ATP2B2']",0.9999670772068849,0,0,5
28,Linoleic acid metabolism,0.196052948821815,5.178766588602654,8.438129553420152,['PLA2G5'],0.9999670772068849,0,0,1
29,Pancreatic secretion,0.19767871911559126,2.017857142857143,3.2711728259036574,"['ATP1B3', 'ATP2B2', 'PLA2G5']",0.9999670772068849,0,0,3
30,Base excision repair,0.20253280373954435,2.502786962683042,3.996583900317894,"['POLD3', 'HMGB1']",0.9999670772068849,0,0,2
31,Hypertrophic cardiomyopathy,0.20462086060636117,1.981018981018981,3.143077727565383,"['MYL3', 'ITGA7', 'CACNA1D']",0.9999670772068849,0,0,3
32,cGMP-PKG signaling pathway,0.20736986870465599,1.6232981452249409,2.553855876384677,"['NFATC2', 'ATP1B3', 'CACNA1D', 'ATP2B2', 'MYLK']",0.9999670772068849,0,0,5
33,DNA replication,0.21244129181182872,2.419178082191781,3.7475236139973793,"['POLD3', 'RFC3']",0.9999670772068849,0,0,2
34,Calcium signaling pathway,0.22175498686746492,1.5050148056165822,2.266826464832347,"['OXTR', 'CACNA1A', 'CACNA1D', 'ATP2B2', 'PLCD4', 'MYLK']",0.9999670772068849,0,0,6
35,Glycosphingolipid biosynthesis,0.23238466807827007,2.26763698630137,3.309301497678889,"['ST8SIA1', 'ST3GAL3']",0.9999670772068849,0,0,2
36,Type II diabetes mellitus,0.23238466807827007,2.26763698630137,3.309301497678889,"['CACNA1A', 'CACNA1D']",0.9999670772068849,0,0,2
37,Nitrogen metabolism,0.23875320336783273,4.027322404371585,5.768434089485524,['GLUD1'],0.9999670772068849,0,0,1
38,alpha-Linolenic acid metabolism,0.23875320336783273,4.027322404371585,5.768434089485524,['PLA2G5'],0.9999670772068849,0,0,1
39,Insulin secretion,0.24008458536543956,1.8152472527472527,2.589929392671204,"['PCLO', 'ATP1B3', 'CACNA1D']",0.9999670772068849,0,0,3
40,Dilated cardiomyopathy,0.24730184549370735,1.785353990272023,2.494399546778791,"['MYL3', 'ITGA7', 'CACNA1D']",0.9999670772068849,0,0,3
41,Non-homologous end-joining,0.2592474208898312,3.6243169398907105,4.8927277662103705,['PRKDC'],0.9999670772068849,0,0,1
42,Primary bile acid biosynthesis,0.2592474208898312,3.6243169398907105,4.8927277662103705,['CYP27A1'],0.9999670772068849,0,0,1
43,Inositol phosphate metabolism,0.269138346934076,1.7012791895604396,2.2329795165490367,"['IPPK', 'ISYNA1', 'PLCD4']",0.9999670772068849,0,0,3
44,GABAergic synapse,0.29118109901824596,1.6247334754797442,2.004612201389348,"['CACNA1A', 'CACNA1D', 'GPHN']",0.9999670772068849,0,0,3
45,Histidine metabolism,0.29859974876982365,3.0198087431693987,3.64989556761321,['MAOA'],0.9999670772068849,0,0,1
46,Endocrine and other factor-regulated calcium reabsorption,0.31258873519645186,1.813013698630137,2.1082936148219336,"['ATP1B3', 'ATP2B2']",0.9999670772068849,0,0,2
47,NOD-like receptor signaling pathway,0.33117668357743835,1.3955287137105319,1.5422033292366975,"['TRAF3', 'ERBIN', 'ANTXR1', 'GBP1']",0.9999670772068849,0,0,4
48,Nucleotide excision repair,0.3324593486729434,1.7264187866927594,1.9011974297085639,"['POLD3', 'RFC3']",0.9999670772068849,0,0,2
49,Cell adhesion molecules,0.33554605973046847,1.4905163329820863,1.627637940872281,"['NTNG2', 'JAM2', 'JAM3']",0.9999670772068849,0,0,3
50,Fat digestion and absorption,0.33586688298822287,2.588017174082748,2.8236312387344022,['PLA2G5'],0.9999670772068849,0,0,1
51,Dopaminergic synapse,0.3434339109277963,1.3689900722490773,1.463122630307074,"['PPP2R2C', 'MAOA', 'CACNA1A', 'CACNA1D']",0.9999670772068849,0,0,4
52,"Parathyroid hormone synthesis, secretion and action",0.35771346603750137,1.431354829381145,1.4714656675133966,"['NR4A2', 'MMP16', 'BGLAP']",0.9999670772068849,0,0,3
53,Folate biosynthesis,0.3711590270200332,2.2641734972677594,2.244078196621118,['GPHN'],0.9999670772068849,0,0,1
54,Oxytocin signaling pathway,0.3740994905666044,1.3068274886456706,1.2849165647552094,"['OXTR', 'NFATC2', 'CACNA1D', 'MYLK']",0.9999670772068849,0,0,4
55,Vascular smooth muscle contraction,0.37977763419080207,1.3766866045347057,1.332865803597152,"['CACNA1D', 'PLA2G5', 'MYLK']",0.9999670772068849,0,0,3
56,Thyroid hormone synthesis,0.3813240759214812,1.542174293208977,1.4868189839660004,"['ATP1B3', 'TTF2']",0.9999670772068849,0,0,2
57,One carbon pool by folate,0.38809731947888354,2.1308261009321763,2.016825087812577,['MTFMT'],0.9999670772068849,0,0,1
58,Gastric acid secretion,0.4193015535039412,1.4207896857373086,1.2349005532826578,"['ATP1B3', 'MYLK']",0.9999670772068849,0,0,2
59,PPAR signaling pathway,0.4193015535039412,1.4207896857373086,1.2349005532826578,"['CYP27A1', 'FABP5']",0.9999670772068849,0,0,2
60,Salivary secretion,0.4193015535039412,1.4207896857373086,1.2349005532826578,"['ATP1B3', 'ATP2B2']",0.9999670772068849,0,0,2
61,Steroid hormone biosynthesis,0.4206209865711675,1.906241012366983,1.6508487894076893,['CYP11A1'],0.9999670772068849,0,0,1
62,Systemic lupus erythematosus,0.4206209865711675,1.906241012366983,1.6508487894076893,['RO60'],0.9999670772068849,0,0,1
63,Protein processing in endoplasmic reticulum,0.42089752084473686,1.184595385115372,1.025108443700879,"['HSPA4L', 'SEL1L', 'EIF2AK3', 'UBE2D1', 'SEC31A']",0.9999670772068849,0,0,5
64,Amphetamine addiction,0.42861226166677335,1.3933614330874604,1.180459411717701,"['MAOA', 'CACNA1D']",0.9999670772068849,0,0,2
65,Protein digestion and absorption,0.42861226166677335,1.3933614330874604,1.180459411717701,"['COL5A2', 'ATP1B3']",0.9999670772068849,0,0,2
66,Mannose type O-glycan biosynthesis,0.43623041885287883,1.810792349726776,1.502205613042937,['ST3GAL3'],0.9999670772068849,0,0,1
67,Epithelial cell signaling in Helicobacter pylori infection,0.43784382095717844,1.3669682088394934,1.12896948221655,"['JAM2', 'JAM3']",0.9999670772068849,0,0,2
68,Necroptosis,0.4447553124085028,1.2350462037962038,1.0006727303818377,"['GLUD1', 'IL33', 'HMGB1']",0.9999670772068849,0,0,3
69,Arachidonic acid metabolism,0.4805867965732722,1.5742456640532192,1.1535244627213985,['PLA2G5'],0.9999670772068849,0,0,1
70,Ovarian steroidogenesis,0.4805867965732722,1.5742456640532192,1.1535244627213985,['CYP11A1'],0.9999670772068849,0,0,1
71,Tryptophan metabolism,0.4805867965732722,1.5742456640532192,1.1535244627213985,['MAOA'],0.9999670772068849,0,0,1
72,Natural killer cell mediated cytotoxicity,0.48273389974400127,1.2486537553141237,0.9093816805433934,"['SHC1', 'NFATC2']",0.9999670772068849,0,0,2
73,Parkinson disease,0.494188094061624,1.0702618615504278,0.7543623827013859,"['GPR37', 'UBA7', 'MAOA', 'DUSP1', 'EIF2AK3', 'UQCRC2']",0.9999670772068849,0,0,6
74,Chemical carcinogenesis,0.49975667519918815,1.0971700475832706,0.761034392406104,"['SULT1A1', 'CACNA1A', 'CACNA1D', 'KLF4']",0.9999670772068849,0,0,4
75,Aldosterone-regulated sodium reabsorption,0.5082064770360913,1.4480874316939891,0.9801632662724336,['ATP1B3'],0.9999670772068849,0,0,1
76,Complement and coagulation cascades,0.5082064770360913,1.4480874316939891,0.9801632662724336,['CD59'],0.9999670772068849,0,0,1
77,Glyoxylate and dicarboxylate metabolism,0.5082064770360913,1.4480874316939891,0.9801632662724336,['MCEE'],0.9999670772068849,0,0,1
78,NF-kappa B signaling pathway,0.5085866474216855,1.1869750729845048,0.8025372064353831,"['TRAF3', 'TRIM25']",0.9999670772068849,0,0,2
79,Fructose and mannose metabolism,0.5214620433403533,1.3922866750735603,0.9065440163398538,['GMDS'],0.9999670772068849,0,0,1
80,Thyroid hormone signaling pathway,0.533337997601995,1.075019040365575,0.6757568762758032,"['THRB', 'ATP1B3', 'PLCD4']",0.9999670772068849,0,0,3
81,"Alanine, aspartate and glutamate metabolism",0.5343612716963454,1.3406193078324227,0.8401435039895176,['GLUD1'],0.9999670772068849,0,0,1
82,Cholesterol metabolism,0.5343612716963454,1.3406193078324227,0.8401435039895176,['CYP27A1'],0.9999670772068849,0,0,1
83,Nicotinate and nicotinamide metabolism,0.5343612716963454,1.3406193078324227,0.8401435039895176,['NADSYN1'],0.9999670772068849,0,0,1
84,Nicotine addiction,0.5469137157468209,1.2926424668227947,0.7800634907353707,['CACNA1A'],0.9999670772068849,0,0,1
85,Cushing syndrome,0.5526373836307443,1.0437711327134405,0.6190118294716783,"['NR4A1', 'CYP11A1', 'CACNA1D']",0.9999670772068849,0,0,3
86,Bacterial invasion of epithelial cells,0.5576953584142825,1.0801881005929257,0.6307676517329341,"['SHC1', 'ACTR3B']",0.9999670772068849,0,0,2
87,"Glycine, serine and threonine metabolism",0.5591286736304535,1.2479743734690032,0.7255419087278556,['MAOA'],0.9999670772068849,0,0,1
88,cAMP signaling pathway,0.561195366656606,1.0119247144040533,0.5845749297179146,"['OXTR', 'ATP1B3', 'CACNA1D', 'ATP2B2']",0.9999670772068849,0,0,4
89,Leukocyte transendothelial migration,0.565534008189866,1.064222401289283,0.6065906425381632,"['JAM2', 'JAM3']",0.9999670772068849,0,0,2
90,Propanoate metabolism,0.5710151949702088,1.2062841530054644,0.6759286091211215,['MCEE'],0.9999670772068849,0,0,1
91,Taste transduction,0.5710151949702088,1.2062841530054644,0.6759286091211215,['CACNA1A'],0.9999670772068849,0,0,1
92,Glycerophospholipid metabolism,0.5809102317145459,1.0336594911937378,0.5614414975263011,"['PLA2G5', 'SELENOI']",0.9999670772068849,0,0,2
93,Focal adhesion,0.5877366213781036,0.9773657955476137,0.5194468097933924,"['SHC1', 'ITGA7', 'PARVB', 'MYLK']",0.9999670772068849,0,0,4
94,Morphine addiction,0.5884473089781809,1.019023731429674,0.5403555646760024,"['CACNA1A', 'PDE7A']",0.9999670772068849,0,0,2
95,Cytosolic DNA-sensing pathway,0.5938379224508198,1.1307206284153006,0.5892737604604,['IL33'],0.9999670772068849,0,0,1
96,Melanogenesis,0.5958835079212113,1.0047945205479452,0.5201922591814707,"['DCT', 'ASIP']",0.9999670772068849,0,0,2
97,Homologous recombination,0.6154495692372146,1.0640469302475088,0.5164907967558121,['POLD3'],0.9999670772068849,0,0,1
98,Legionellosis,0.6154495692372146,1.0640469302475088,0.5164907967558121,['HSF1'],0.9999670772068849,0,0,1
99,Cytokine-cytokine receptor interaction,0.617586790432916,0.9643835616438357,0.4647708369997619,"['IL33', 'LEPR']",0.9999670772068849,0,0,2
100,JAK-STAT signaling pathway,0.617586790432916,0.9643835616438357,0.4647708369997619,"['LEPR', 'PIAS1']",0.9999670772068849,0,0,2
101,Ferroptosis,0.6258214026828585,1.033567525370804,0.4844230196008874,['MAP1LC3B2'],0.9999670772068849,0,0,1
102,Bile secretion,0.6359142345788381,1.0047814207650274,0.4548560849281684,['ATP1B3'],0.9999670772068849,0,0,1
103,Cocaine addiction,0.6359142345788381,1.0047814207650274,0.4548560849281684,['MAOA'],0.9999670772068849,0,0,1
104,Glutathione metabolism,0.6359142345788381,1.0047814207650274,0.4548560849281684,['LAP3'],0.9999670772068849,0,0,1
105,Various types of N-glycan biosynthesis,0.6359142345788381,1.0047814207650274,0.4548560849281684,['ST3GAL3'],0.9999670772068849,0,0,1
106,MicroRNAs in cancer,0.6631734285158724,0.8812650763870276,0.3619520831287584,"['MMP16', 'SHC1', 'HMGA2']",0.9999670772068849,0,0,3
107,Antigen processing and presentation,0.664592576293761,0.9272803699033207,0.37886922734089773,['LGMN'],0.9999670772068849,0,0,1
108,Basal transcription factors,0.664592576293761,0.9272803699033207,0.37886922734089773,['TAF1'],0.9999670772068849,0,0,1
109,Other types of O-glycan biosynthesis,0.664592576293761,0.9272803699033207,0.37886922734089773,['ST3GAL3'],0.9999670772068849,0,0,1
110,Alcoholism,0.6647221830557806,0.881590377547611,0.360029252079437,"['MAOA', 'SHC1']",0.9999670772068849,0,0,2
111,Cholinergic synapse,0.6647221830557806,0.881590377547611,0.360029252079437,"['CACNA1A', 'CACNA1D']",0.9999670772068849,0,0,2
112,Spinocerebellar ataxia,0.6684058147388756,0.8740916341722793,0.3521363658978943,"['AFG3L2', 'CACNA1A', 'PUM1']",0.9999670772068849,0,0,3
113,Spliceosome,0.6735787401994482,0.8670329670329671,0.3426084046734344,"['SF3B3', 'PPIH', 'SNRPF']",0.9999670772068849,0,0,3
114,Neuroactive ligand-receptor interaction,0.6786922309036575,0.8600863422291993,0.33335873440342284,"['OXTR', 'THRB', 'LEPR']",0.9999670772068849,0,0,3
115,"Valine, leucine and isoleucine degradation",0.6824484522358731,0.8819139011062241,0.3369513296275188,['MCEE'],0.9999670772068849,0,0,1
116,Phosphatidylinositol signaling system,0.6834464917517795,0.8502820306204674,0.3236232176141547,"['IPPK', 'PLCD4']",0.9999670772068849,0,0,2
117,Amino sugar and nucleotide sugar metabolism,0.69101763727197,0.8608508977361436,0.3181618241264523,['GMDS'],0.9999670772068849,0,0,1
118,Renin secretion,0.69101763727197,0.8608508977361436,0.3181618241264523,['CACNA1D'],0.9999670772068849,0,0,1
119,Non-alcoholic fatty liver disease,0.6936767187063915,0.8398926654740608,0.3071901126408274,"['LEPR', 'EIF2AK3', 'UQCRC2']",0.9999670772068849,0,0,3
120,Measles,0.7013076048670486,0.8211083437110834,0.29133636719227735,"['TRAF3', 'EIF2AK3']",0.9999670772068849,0,0,2
121,Glutamatergic synapse,0.7127450771831838,0.8027397260273973,0.27183292382428004,"['CACNA1A', 'CACNA1D']",0.9999670772068849,0,0,2
122,"Growth hormone synthesis, secretion and action",0.7183251938102473,0.7938581965979227,0.26263440643136776,"['SHC1', 'CACNA1D']",0.9999670772068849,0,0,2
123,Drug metabolism,0.7230491671441456,0.7857567118080304,0.25480365804079147,['MAOA'],0.9999670772068849,0,0,1
124,VEGF signaling pathway,0.7230491671441456,0.7857567118080304,0.25480365804079147,['NFATC2'],0.9999670772068849,0,0,1
125,Cell cycle,0.7238140055259242,0.7851697438951757,0.25378320692624473,"['PRKDC', 'ORC3']",0.9999670772068849,0,0,2
126,Glycosaminoglycan biosynthesis,0.7305254768083973,0.7689803511219626,0.2414530421163644,['ST3GAL3'],0.9999670772068849,0,0,1
127,Hedgehog signaling pathway,0.7305254768083973,0.7689803511219626,0.2414530421163644,['CSNK1G1'],0.9999670772068849,0,0,1
128,Long-term depression,0.7305254768083973,0.7689803511219626,0.2414530421163644,['CACNA1A'],0.9999670772068849,0,0,1
129,Lipid and atherosclerosis,0.7310482927508728,0.7903665677388305,0.24760268517928694,"['TRAF3', 'EIF2AK3', 'NFATC2']",0.9999670772068849,0,0,3
130,IL-17 signaling pathway,0.7378004966811134,0.7529030054644809,0.22894411665771616,['TRAF3'],0.9999670772068849,0,0,1
131,B cell receptor signaling pathway,0.7517681423610825,0.7226775956284153,0.2061996644041812,['NFATC2'],0.9999670772068849,0,0,1
132,GnRH secretion,0.7517681423610825,0.7226775956284153,0.2061996644041812,['CACNA1D'],0.9999670772068849,0,0,1
133,p53 signaling pathway,0.7517681423610825,0.7226775956284153,0.2061996644041812,['AIFM2'],0.9999670772068849,0,0,1
134,RNA transport,0.75665948635096,0.7568585260892953,0.21104390473358997,"['XPO1', 'CLNS1A', 'EIF4EBP2']",0.9999670772068849,0,0,3
135,AMPK signaling pathway,0.7597535894637226,0.7292652552926525,0.20037374026383184,"['PPP2R2C', 'LEPR']",0.9999670772068849,0,0,2
136,Apelin signaling pathway,0.7645443479661946,0.7219178082191781,0.19381706128581797,"['MYL3', 'MYLK']",0.9999670772068849,0,0,2
137,Prolactin signaling pathway,0.7649936306370638,0.694777217318201,0.18612232019656583,['SHC1'],0.9999670772068849,0,0,1
138,Purine metabolism,0.7692521156726025,0.7147158551471585,0.1874960662815704,"['AMPD3', 'PDE7A']",0.9999670772068849,0,0,2
139,Adipocytokine signaling pathway,0.777516293134917,0.668943533697632,0.1683400947003145,['LEPR'],0.9999670772068849,0,0,1
140,Central carbon metabolism in cancer,0.777516293134917,0.668943533697632,0.1683400947003145,['PDK1'],0.9999670772068849,0,0,1
141,ECM-receptor interaction,0.7835257843979238,0.6567312468951814,0.16021044699771841,['ITGA7'],0.9999670772068849,0,0,1
142,Th1 and Th2 cell differentiation,0.7835257843979238,0.6567312468951814,0.16021044699771841,['NFATC2'],0.9999670772068849,0,0,1
143,Human papillomavirus infection,0.7867634268960783,0.756592692325549,0.18145186776213318,"['PPP2R2C', 'NFX1', 'TRAF3', 'ITGA7', 'ISG15']",0.9999670772068849,0,0,5
144,Transcriptional misregulation in cancer,0.7915807465166141,0.6807443783923495,0.15910588233498232,"['NR4A3', 'HMGA2']",0.9999670772068849,0,0,2
145,Lysine degradation,0.7950634376380213,0.633592177164222,0.14530383029729932,['PLOD2'],0.9999670772068849,0,0,1
146,Toll-like receptor signaling pathway,0.7950634376380213,0.633592177164222,0.14530383029729932,['TRAF3'],0.9999670772068849,0,0,1
147,Yersinia infection,0.799966143802792,0.6680365296803653,0.1490963157093557,"['NFATC2', 'ACTR3B']",0.9999670772068849,0,0,2
148,Synaptic vesicle cycle,0.8006001824753757,0.6226210665159224,0.13846694322036718,['CACNA1A'],0.9999670772068849,0,0,1
149,Regulation of actin cytoskeleton,0.8019693487167868,0.6976249556894718,0.15395528688914226,"['ITGA7', 'ACTR3B', 'MYLK']",0.9999670772068849,0,0,3
150,Axon guidance,0.8121284095912356,0.6842224231464737,0.14238450456744742,"['SEMA5A', 'NTNG2', 'NFATC2']",0.9999670772068849,0,0,3
151,Mitophagy,0.8212948165158833,0.5822756918737881,0.11463444355579962,['EIF2AK3'],0.9999670772068849,0,0,1
152,Retrograde endocannabinoid signaling,0.8233553102849156,0.6325883201153569,0.12295457597991072,"['CACNA1A', 'CACNA1D']",0.9999670772068849,0,0,2
153,Neutrophil extracellular trap formation,0.8261246421535394,0.5729898516783762,0.10944657288992964,['HMGB1'],0.9999670772068849,0,0,1
154,TGF-beta signaling pathway,0.8261246421535394,0.5729898516783762,0.10944657288992964,['RGMB'],0.9999670772068849,0,0,1
155,Insulin signaling pathway,0.8270064345675457,0.6270399047051817,0.11910171732769217,"['SHC1', 'TRIP10']",0.9999670772068849,0,0,2
156,Glioma,0.8308242777948872,0.563994193989071,0.10452897231440458,['SHC1'],0.9999670772068849,0,0,1
157,Th17 cell differentiation,0.8308242777948872,0.563994193989071,0.10452897231440458,['NFATC2'],0.9999670772068849,0,0,1
158,Cellular senescence,0.8442633520463423,0.6006849315068493,0.1016904353454782,"['NFATC2', 'CACNA1D']",0.9999670772068849,0,0,2
159,Wnt signaling pathway,0.8507184959544226,0.5907478104648551,0.0955085598523333,"['RNF43', 'NFATC2']",0.9999670772068849,0,0,2
160,MAPK signaling pathway,0.852131544392881,0.6599944398109536,0.1056085939903365,"['NR4A1', 'DUSP1', 'CACNA1A', 'CACNA1D']",0.9999670772068849,0,0,4
161,C-type lectin receptor signaling pathway,0.8524888722781893,0.5229270610596342,0.08345660860671136,['NFATC2'],0.9999670772068849,0,0,1
162,Chagas disease,0.8524888722781893,0.5229270610596342,0.08345660860671136,['PPP2R2C'],0.9999670772068849,0,0,1
163,Chronic myeloid leukemia,0.8524888722781893,0.5229270610596342,0.08345660860671136,['SHC1'],0.9999670772068849,0,0,1
164,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.8524888722781893,0.5229270610596342,0.08345660860671136,['NFATC2'],0.9999670772068849,0,0,1
165,Hepatitis B,0.8569295354703049,0.5811312417145382,0.08972642318265588,"['TRAF3', 'NFATC2']",0.9999670772068849,0,0,2
166,PI3K-Akt signaling pathway,0.8592354180066364,0.6508856562332498,0.09874738207581718,"['NR4A1', 'PPP2R2C', 'ITGA7', 'SGK2']",0.9999670772068849,0,0,4
167,GnRH signaling pathway,0.8603588909873096,0.5081197567921188,0.07642408823543323,['CACNA1D'],0.9999670772068849,0,0,1
168,T cell receptor signaling pathway,0.8603588909873096,0.5081197567921188,0.07642408823543323,['NFATC2'],0.9999670772068849,0,0,1
169,Autophagy,0.8629041100687683,0.5718199608610568,0.08431582897743449,"['EIF2AK3', 'HMGB1']",0.9999670772068849,0,0,2
170,Small cell lung cancer,0.8713856535342267,0.4874095406882292,0.06710197811127398,['TRAF3'],0.9999670772068849,0,0,1
171,AGE-RAGE signaling pathway in diabetic complications,0.8748647433948964,0.4808743169398907,0.06428615602420977,['PLCD4'],0.9999670772068849,0,0,1
172,Fc gamma R-mediated phagocytosis,0.8748647433948964,0.4808743169398907,0.06428615602420977,['ACTR3B'],0.9999670772068849,0,0,1
173,Circadian entrainment,0.8815438584430282,0.46831310765736994,0.05904516203322139,['CACNA1D'],0.9999670772068849,0,0,1
174,ErbB signaling pathway,0.8815438584430282,0.46831310765736994,0.05904516203322139,['SHC1'],0.9999670772068849,0,0,1
175,Kaposi sarcoma-associated herpesvirus infection,0.8845861463329044,0.5373543242690656,0.06589864885507257,"['TRAF3', 'NFATC2']",0.9999670772068849,0,0,2
176,Osteoclast differentiation,0.8847488671552809,0.46227406473308114,0.05660612497962644,['NFATC2'],0.9999670772068849,0,0,1
177,TNF signaling pathway,0.8847488671552809,0.46227406473308114,0.05660612497962644,['TRAF3'],0.9999670772068849,0,0,1
178,Platelet activation,0.8938542132601313,0.44505160898603524,0.04994039351540497,['MYLK'],0.9999670772068849,0,0,1
179,mRNA surveillance pathway,0.8938542132601313,0.44505160898603524,0.04994039351540497,['PPP2R2C'],0.9999670772068849,0,0,1
180,Shigellosis,0.8994323087754561,0.5615985576923077,0.05952466381364209,"['UBE2D1', 'ACTR3B', 'PLCD4']",0.9999670772068849,0,0,3
181,HIF-1 signaling pathway,0.9048883323088021,0.42397942783670844,0.04237408656758942,['PDK1'],0.9999670772068849,0,0,1
182,Longevity regulating pathway,0.9048883323088021,0.42397942783670844,0.04237408656758942,['EIF4EBP2'],0.9999670772068849,0,0,1
183,Epstein-Barr virus infection,0.9051666680192143,0.5031899607242073,0.05013592986914949,"['TRAF3', 'ISG15']",0.9999670772068849,0,0,2
184,Estrogen signaling pathway,0.912406315062977,0.4094324391455539,0.03753261733219281,['SHC1'],0.9999670772068849,0,0,1
185,Insulin resistance,0.912406315062977,0.4094324391455539,0.03753261733219281,['OGA'],0.9999670772068849,0,0,1
186,Coronavirus disease,0.9239937385097098,0.4699435938759065,0.03714903351478695,"['TRAF3', 'ISG15']",0.9999670772068849,0,0,2
187,Prion disease,0.9247483309175499,0.5203057811753464,0.04070542202810479,"['EIF2AK3', 'CACNA1D', 'UQCRC2']",0.9999670772068849,0,0,3
188,Human immunodeficiency virus 1 infection,0.9273108196410939,0.4638091029606717,0.03500203730658671,"['BST2', 'NFATC2']",0.9999670772068849,0,0,2
189,Relaxin signaling pathway,0.9277230921796791,0.3790624101236698,0.028438013601606523,['SHC1'],0.9999670772068849,0,0,1
190,Human T-cell leukemia virus 1 infection,0.9320316393220696,0.4548985607768337,0.032019635125050676,"['XPO1', 'NFATC2']",0.9999670772068849,0,0,2
191,Fluid shear stress and atherosclerosis,0.9334401876027393,0.367374818779971,0.025304186530082384,['DUSP1'],0.9999670772068849,0,0,1
192,Signaling pathways regulating pluripotency of stem cells,0.9369987211204911,0.3599726775956284,0.023424632219158623,['KLF4'],0.9999670772068849,0,0,1
193,Sphingolipid signaling pathway,0.9369987211204911,0.3599726775956284,0.023424632219158623,['PPP2R2C'],0.9999670772068849,0,0,1
194,Gastric cancer,0.9387061808282735,0.3563815397933236,0.02254211429629895,['SHC1'],0.9999670772068849,0,0,1
195,Ras signaling pathway,0.9392620607678838,0.4407765358433482,0.02761938997611169,"['SHC1', 'PLA2G5']",0.9999670772068849,0,0,2
196,Neurotrophin signaling pathway,0.9419838807243607,0.3494084566820521,0.020883135870130187,['SHC1'],0.9999670772068849,0,0,1
197,Oxidative phosphorylation,0.9419838807243607,0.3494084566820521,0.020883135870130187,['UQCRC2'],0.9999670772068849,0,0,1
198,Breast cancer,0.9435565759335116,0.34602248844052125,0.020103543973747126,['SHC1'],0.9999670772068849,0,0,1
199,FoxO signaling pathway,0.9450867499575324,0.34270101483216237,0.019355258733259353,['SGK2'],0.9999670772068849,0,0,1
200,Lysosome,0.9480240897976387,0.33624431847198816,0.017947163520497484,['LGMN'],0.9999670772068849,0,0,1
201,Apoptosis,0.9494334570921867,0.3331056466302368,0.017284796453968566,['EIF2AK3'],0.9999670772068849,0,0,1
202,Phospholipase D signaling pathway,0.9508047078280056,0.3300245650975084,0.016648614608408684,['SHC1'],0.9999670772068849,0,0,1
203,Chemokine signaling pathway,0.9521388701196106,0.32699950322901145,0.016037488829651433,['SHC1'],0.9999670772068849,0,0,1
204,Pathways of neurodegeneration,0.9538007694278227,0.5579553324099723,0.02639154746513356,"['DNAH1', 'GPR37', 'UBA7', 'EIF2AK3', 'CACNA1D', 'UQCRC2']",0.9999670772068849,0,0,6
205,Hippo signaling pathway,0.9615915649854586,0.3046448087431694,0.01193156232489925,['PPP2R2C'],0.9999670772068849,0,0,1
206,Herpes simplex virus 1 infection,0.9621012537152775,0.540543943591035,0.020884229053366822,"['BST2', 'ZNF682', 'TRAF3', 'ZNF627', 'EIF2AK3', 'ZNF77']",0.9999670772068849,0,0,6
207,Amyotrophic lateral sclerosis,0.9669373411647754,0.4733548610731031,0.015914939640744863,"['SETX', 'DNAH1', 'EIF2AK3', 'UQCRC2']",0.9999670772068849,0,0,4
208,Ribosome,0.970832273787065,0.2806309767759563,0.008307115021025546,['MRPS10'],0.9999670772068849,0,0,1
209,Salmonella infection,0.9752599833955041,0.354618201546182,0.008883609324768288,"['ACBD3', 'ACTR3B']",0.9999670772068849,0,0,2
210,Hepatocellular carcinoma,0.9752744215232998,0.2679430715276079,0.006708327133013595,['SHC1'],0.9999670772068849,0,0,1
211,Viral carcinogenesis,0.9778541789857418,0.26009741031123784,0.0058248090162252575,['TRAF3'],0.9999670772068849,0,0,1
212,Pathogenic Escherichia coli infection,0.9817394824438791,0.24740908234407386,0.004559575867499985,['ACTR3B'],0.9999670772068849,0,0,1
213,Rap1 signaling pathway,0.9849445858585816,0.2358894161633592,0.0035784182419304946,['SIPA1L2'],0.9999670772068849,0,0,1
214,Diabetic cardiomyopathy,0.9865173012911902,0.22977091214796133,0.003119005858498097,['UQCRC2'],0.9999670772068849,0,0,1
215,Alzheimer disease,0.9871161908680035,0.3664477645642029,0.004751920633591898,"['EIF2AK3', 'CACNA1D', 'UQCRC2']",0.9999670772068849,0,0,3
216,Human cytomegalovirus infection,0.9875883029329086,0.22538406021239302,0.0028149039088188597,['NFATC2'],0.9999670772068849,0,0,1
217,Huntington disease,0.9936762636695473,0.2753689109853493,0.0017468896614221548,"['DNAH1', 'UQCRC2']",0.9999670772068849,0,0,2
218,Thermogenesis,0.9951477384831985,0.18519776890625442,0.0009008152744402569,['UQCRC2'],0.9999670772068849,0,0,1
219,Endocytosis,0.9977014562270136,0.1621336313959265,0.0003731002068712515,['ACTR3B'],0.9999670772068849,0,0,1
220,Pathways in cancer,0.9999670772068849,0.09373183350773166,3.085964562435883e-06,['TRAF3'],0.9999670772068849,0,0,1
